?Not sure what you need?
No clipboard.The old way×Drive to a clinic×Sit in a waiting room×Wait weeks for a visitThe KIN way✓60-second care finder✓Reviewed in 24 hours or less✓Rx sent to the manufacturer pharmacyRx by KIN.
Filled by the maker.FDA-approved brandPrescribed only if it fits youFilled by the manufacturer pharmacy
Brand-name GLP-1 medicationsWhat it does.Injection or pillWegovy® and Zepbound® are weekly injections. The Wegovy® pill and Foundayo™ are daily tablets.One or two pathwaysSemaglutide and orforglipron act on GLP-1. Tirzepatide acts on both GLP-1 and GIP.Your health historyHeart disease or sleep apnea can point toward a medicine with that specific FDA-approved use.Your routineSome pills need an empty stomach and a wait before eating. Others do not.Made to fitOnline review, 24 hours or less
your day.Weekly injection, Daily pill. At home. On your schedule.Did you knowFirstWegovy® was the first weight-management medicine FDA-approved to reduce the risk of heart attack, stroke and cardiovascular death in adults with established heart disease and obesity or overweight.
Source: FDADid you knowFirstZepbound® is the first medicine FDA-approved to treat moderate to severe obstructive sleep apnea in adults with obesity.
Source: FDAFDA-approved brand-name medicationWeight care · FDA-approvedBrand-name GLP-1 medications, compared in plain English
Consult only. If prescribed, your prescription is sent to LillyDirect® (Zepbound®, Foundayo™) or NovoCare® Pharmacy (Wegovy®), which handles fulfillment and medication pricing.Weekly pens, vials or a daily pill. Here is how the FDA-approved options differ, so you and a licensed provider can pick what fits your body and routine.
- FDA-approved
- Pens, vials or pills
- Reviewed online in 24 hrs
1. Choose your supplyNo auto-subscribe. Pick 30 or 90 days, skip a month when you need to.Already on a GLP-1? To continue at your current dose, share a prescription from the last 30 days. Otherwise you start at the lowest dose, and your provider can talk with you about adjusting it.
2. How you get careStart my online visit →Online review, 24 hours or lessShips discreetly to your door
- Shipping & supplies included
- No auto-subscribe
- No hidden fees or sign-ups
Prescription required. If a provider decides treatment is not appropriate, you are not charged for treatment.
Snoring or poor sleepTired of starting over every MondayWeight that won't budgeConstant cravings and food noise
Feel like you again.
Weight care that works with your body, not against it.
What are brand-name GLP-1 medications?
Brand-name GLP-1 medications are FDA-approved prescription medicines made by their manufacturers. Through KIN Meds, a licensed provider may prescribe Wegovy® (semaglutide weekly injection), the Wegovy® pill (daily oral semaglutide), Zepbound® (tirzepatide weekly injection, as a pen or single-dose vial) and Foundayo™ (orforglipron daily tablet).
Wegovy® is FDA-approved to reduce the risk of major adverse cardiovascular events (heart attack, stroke or cardiovascular death) in adults with established cardiovascular disease and either obesity or overweight, and for chronic weight management in adults with obesity, or overweight plus at least one weight-related condition, alongside a reduced-calorie diet and more physical activity. Zepbound® is FDA-approved for chronic weight management in adults with obesity, or overweight plus at least one weight-related condition, alongside a reduced-calorie diet and more physical activity, and to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity. Foundayo™ and the Wegovy® pill are FDA-approved for chronic weight management in adults with obesity, or overweight plus a weight-related condition.
How to choose between them
1Injection or pillWegovy® and Zepbound® are weekly injections. The Wegovy® pill and Foundayo™ are daily tablets.→2One or two pathwaysSemaglutide and orforglipron act on GLP-1. Tirzepatide acts on both GLP-1 and GIP.→3Your health historyHeart disease or sleep apnea can point toward a medicine with that specific FDA-approved use.→4Your routineSome pills need an empty stomach and a wait before eating. Others do not.Brand-name GLP-1 medications in 60 seconds
A quick, plain-English explainer from the KIN Meds care team: what it is, who it may fit, and what to expect.
How your care works What to expect
Step 1 of 4Day 1
Complete your online intake. A licensed provider reviews it in 24 hours or less.
Step 2 of 4Your match
If treatment is appropriate, your provider recommends a medicine and starting dose.
Step 3 of 4Delivery
Your prescription is filled by a licensed U.S. pharmacy and shipped to you.
Step 4 of 4Step-up
Doses increase gradually on the schedule in the label, as your provider decides.
FirstWegovy® was the first weight-management medicine FDA-approved to reduce the risk of heart attack, stroke and cardiovascular death in adults with established heart disease and obesity or overweight.
FirstZepbound® is the first medicine FDA-approved to treat moderate to severe obstructive sleep apnea in adults with obesity.
Your turn.Start my online visit →
Who it may fit
May fit you if
- Adults with obesity, or overweight plus a weight-related condition
- Adults with established heart disease and obesity or overweight
- Adults with obesity and moderate to severe obstructive sleep apnea
- People who want an FDA-approved medicine with a full label
Probably not for you if
- anyone with a personal or family history of medullary thyroid carcinoma or MEN 2
- people who are pregnant, trying to get pregnant, or breastfeeding
- a known serious allergy to the medicine or its ingredients
- use with another GLP-1 medicine
- anyone under 18 through KIN Meds
Did you know The numbers.
FirstWegovy® was the first weight-management medicine FDA-approved to reduce the risk of heart attack, stroke and cardiovascular death in adults with established heart disease and obesity or overweight.
Source: FDAFirstZepbound® is the first medicine FDA-approved to treat moderate to severe obstructive sleep apnea in adults with obesity.
Source: FDA4 in 10U.S. adults have obesity, a chronic disease linked to heart disease, type 2 diabetes and some cancers.
Source: CDCReal providers.
Real answers.Every intake is reviewed by a licensed provider, not a bot. Physicians, nurse practitioners and physician assistants who know hormones, weight and healthy aging, and who treat you like a person.
- Licensed in the state where you live
- Review in 24 hours or less
- Message your care team any time
- Video visits for TRT and hormone care ages 35 to 39
Images show models.
Nurse practitioner
Physician
Physician assistant
Physician
This is an FDA-approved prescription medicine. A licensed provider decides whether treatment is appropriate. Prescription required. Read the full Prescribing Information and Medication Guide from the manufacturer before you start.
Boxed warning: risk of thyroid C-cell tumors. Do not use if you or a family member has had medullary thyroid carcinoma (MTC), or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
All product safety information →Full safety information
Important: WARNING: risk of thyroid C-cell tumors. In studies with rodents, GLP-1 medicines including semaglutide, tirzepatide and orforglipron and medicines like it caused thyroid C-cell tumors. It is not known if they cause these tumors, including medullary thyroid carcinoma (MTC), in people. Do not use if you or any family member has ever had MTC, or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your provider right away about a lump or swelling in your neck, trouble swallowing, hoarseness or shortness of breath.
The most common side effects are nausea, vomiting, diarrhea, constipation, belly pain and lower appetite. They are most likely when you start or step up a dose and often ease with time. Serious but less common risks include pancreatitis, gallbladder problems, low blood sugar (especially with insulin or a sulfonylurea), kidney problems from dehydration, serious allergic reactions, and changes in mood. Get emergency care for severe belly pain that will not go away, signs of an allergic reaction, or thoughts of self-harm.
Not for use during pregnancy. Stop at least 2 months before a planned pregnancy and tell your provider if you are breastfeeding. Tell the care team if you have surgery planned, since these medicines can affect anesthesia and how your stomach empties.
Zepbound® may make birth control pills less effective after starting and after each dose increase. Ask your provider about a backup method.
Sources & citations
- FDA
- FDA
- CDC
Good questions.
Kind answers.
What is the difference between Wegovy and Zepbound?
Wegovy® contains semaglutide, which acts on the GLP-1 receptor. Zepbound® contains tirzepatide, which acts on both GLP-1 and GIP receptors. Both are FDA-approved weekly injections for chronic weight management. Wegovy® is also approved to lower major cardiovascular risk in certain adults with heart disease, and Zepbound® is also approved for moderate to severe sleep apnea in adults with obesity.
Is there an FDA-approved GLP-1 pill for weight loss?
Yes. The Wegovy® pill (oral semaglutide) and Foundayo™ (orforglipron) are FDA-approved daily tablets for chronic weight management in adults with obesity, or overweight plus a weight-related condition. The Wegovy® pill is taken on an empty stomach with a sip of water and a wait before eating. Foundayo™ can be taken any time of day, with or without food.
Which brand-name GLP-1 is right for me?
It depends on your health history, other conditions like heart disease or sleep apnea, whether you prefer a weekly injection or daily pill, and insurance or budget. A licensed provider reviews your intake and decides whether treatment is appropriate, then recommends the option that fits. You can share your preferences in your intake so the provider knows what matters to you.
Does insurance cover brand-name GLP-1 medications?
Coverage depends on your plan, your diagnosis and the specific medicine. Some plans cover weight management medicines and some do not, and many require prior authorization. The care team can explain your options, including manufacturer programs where available. KIN Meds pricing is shown at checkout before you pay, so there are no surprises.
What is the boxed warning on GLP-1 medications?
GLP-1 medicines carry a boxed warning because they caused thyroid C-cell tumors in rodent studies. It is not known if they cause these tumors, including medullary thyroid carcinoma, in people. They should not be used by anyone with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Report neck lumps, trouble swallowing or hoarseness.
What happens if the provider says treatment is not right for me?
If a licensed provider reviews your intake and decides treatment is not appropriate, you are not charged for treatment. The provider may explain why, suggest a different option in KIN Meds care, or recommend you see a local doctor first. That decision is based on your health history, current medicines and safety, not on which product you picked in the quiz.
Pairs well with You might also like.
Find my care in 60 seconds →Ready when
you are.A few quick questions, then a licensed provider reviews your intake in 24 hours or less. If treatment is not appropriate, you are not charged for treatment.
General education, not medical advice. Prescription required. A licensed provider decides whether treatment is appropriate for you. Compounded medications are prepared by a licensed 503A pharmacy and are not FDA-approved. Product imagery is illustrative; actual medication form and appearance may differ.
